Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery
- PMID: 22915867
- PMCID: PMC3417946
- DOI: 10.2147/lra.s7709
Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery
Abstract
Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil has been used for a variety of anesthetic and analgesic applications; however, concerns regarding a potential for rapid induction of tolerance and/or induced hyperalgesia, coupled with an ultrarapid offset of effect, make the drug less than optimal for use in the pharmacologic management of pain.
Keywords: hyperalgesia; intravenous anesthesia; rapid offset; regional anesthesia; tolerance.
References
-
- Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B) Anesth Analg. 1993;77:1031–1040. - PubMed
-
- Jablonka DH, Davis PJ. Opioids in pediatric anesthesia. Anesthesiol Clin North America. 2005;23:621–634. viii. - PubMed
-
- Ross AK, Davis PJ, Dear Gd GL, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg. 2001;93:1393–1401. - PubMed
-
- Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881–892. - PubMed
-
- Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83:968–975. - PubMed
LinkOut - more resources
Full Text Sources
